Spahn, Martin <br/><br/>
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.  [electronic resource] 

 -  International journal of cancer  Jul 2010 
 - 394-403 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.24715  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--genetics<br/>Cohort Studies<br/>Computational Biology<br/>Disease Progression<br/>Humans<br/>Lymphatic Metastasis<br/>Male<br/>MicroRNAs--physiology<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnosis<br/>Oligonucleotide Array Sequence Analysis<br/>Prostatic Hyperplasia--genetics<br/>Prostatic Neoplasms--genetics<br/>RNA, Messenger--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction